Preventable drug-related morbidity in primary care part I - Impact of preventable drug-related morbidity
DOI:
https://doi.org/10.32385/rpmgf.v21i3.10137Keywords:
Morbidity, Primary Care, Safety, Therapy, Preventability, CostsAbstract
Objective: To review the evidence on the magnitude and implications of preventable drug-related morbidity in primary care. Methods: Multiple formats were used to systematically search the literature on preventable drug-related morbidity (PDRM) in primary care. We looked for studies in adults examining avoidable morbidity caused by primary care usage of drugs. Nine electronic databases were searched and references of retrieved papers scanned. In an attempt to find Portuguese data we conducted a hand-search in a Portuguese journal and mailed requests to experts. Results: More than 100 articles were identified as potentially relevant. False positives included studies investigating inpatients and papers not providing quantitative estimates for preventability of drug-related morbidity. References that met our inclusion criteria were subsequently divided into reviews and original articles. Given the space available for this work original articles were excluded where relevant reviews had been published. Preventable drug-related hospital admissions are the most well studied issue (n=5 meta-analytic reviews), followed by preventable drugrelated emergency department visits (n=1 systematic review); little is known about preventable drug-related morbidity that is managed in primary care facilities (n=3 original studies). We found evidence that PDRM resulting in hospitalisation is a common problem; less serious drug-related injuries appear to be even more frequent.Downloads
Downloads
Published
Issue
Section
License
The authors will assign to the RPMGF the sole right to publish and distribute the content of the manuscript specified in this declaration via physical, electronic, broadcasting or any other medium that may come into existence. They also grant the RPMGF the right to use and exploit this manuscript, in particular by assigning, selling or licensing its content. This permission is permanent and takes effect from the moment the manuscript is submitted, has the maximum duration allowed by applicable Portuguese or international law and is of worldwide scope. The authors further declare that this assignment is made free of charge. If the RPMGF informs the authors that it is not going to publish their manuscript, the exclusive assignment of rights ceases forthwith.
The authors authorise the RPMGF (or any entity it may appoint) to act on their behalf when it believes that copyright may have been infringed.